about
Diagnostic Value of Cell-free Circulating MicroRNAs for Obesity and Type 2 Diabetes: A Meta-analysis.Dilated Cardiomyopathy Revealing Cushing Disease: A Case Report and Literature Review.Combination chemotherapy with 5-fluorouracil and dacarbazine in advanced medullary thyroid cancer, a possible alternative?miRNA-375 a Sensor of Glucotoxicity Is Altered in the Serum of Children with Newly Diagnosed Type 1 DiabetesImprovement of Glucose Control and Reduction of Hypoglycemia Following Intravenous Immune Globulins in a Child With Type 1 Diabetes and High Levels of Insulin Antibodies.Comment on Jackson et al. Insulitis in Autoantibody-Positive Pancreatic Donor With History of Gestational Diabetes Mellitus. Diabetes Care 2017;40:723-725.Screening of ZnT8 autoantibodies in the diagnosis of autoimmune diabetes in a large French cohort.Anti-Programmed Death 1 (PD-1) Antibodies and the Pancreas: A Diabetic Storm Ahead?Nivolumab-Induced Acute Diabetes Mellitus and Hypophysitis in a Patient with Advanced Pulmonary Pleomorphic Carcinoma with a Prolonged Tumor Response.Long-Term Effects of Continuous Subcutaneous Insulin Infusion on Glucose Control and Microvascular Complications in Patients With Type 1 Diabetes.Diabetes mellitus induced by PD-1 and PD-L1 inhibitors: description of pancreatic endocrine and exocrine phenotypeAn old retrocardiac mass fortuitously reclassified as paraganglioma[Nephrotic syndrome revealed by pulmonary embolism: about four cases]An unusual cause of cardiothyreosisMultiple autoantibodies at onset do not accurately predict long-term pancreatic beta-cell fate in a 13-year-old obese child with immediate insulin-requiring diabetesDramatic change in skin color after bilateral adrenalectomy in Cushing's diseaseHibernoma and multiple endocrine neoplasia type 1 syndrome: A non-fortuitous association? A case report and literature reviewBilateral vertebral artery dissection revealing Cushing's syndromeVery high titres of ZnT8 autoantibodies at type 1 diabetes onset and presence of autoantibodies related to other autoimmune disordersThe 36% coefficient of variation for glucose proposed for separating stable and labile diabetes is clinically relevant: A continuous glucose monitoring-based study in a large population of type 1 diabetes patientsNecrobiosis LipoidicaFulminant diabetes induced by PD-1 and PD-L1 inhibitors: what about glucose variability?All about skin manifestations of insulin resistance and type 2 diabetes: acanthosis nigricans and acrochordonsInappropriate glucagon and GLP-1 secretion in individuals with long-standing type 1 diabetes: effects of residual C-peptideHave You Ever Seen a LEOPARD?The multifaceted nature of diabetes mellitus induced by checkpoint inhibitorsAcquired Generalized Lipodystrophy: A New Cause of Anti-PD-1 Immune-Related DiabetesSudden enlargement of the neckPhenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study
P50
Q36998610-D6913653-E606-46EB-ABA8-FFD4C103ED02Q38637130-54168E3B-F837-4D8A-AF18-ECBDE87C592AQ40757352-B3EF34DB-7E12-45CF-B380-BA6B897167E8Q42739726-C8782CF0-A0C1-49D4-BE14-3D77B6BB33B1Q48310155-E76357A1-CEEF-425D-BEB7-CBFFFD1E226DQ48319798-EDC8FFD2-A161-4294-A335-A2629BEA3C57Q49392584-CF810F47-FB6B-4571-AC47-7F202E411403Q49790990-C96CD080-2844-4C42-94A5-9646794881BEQ50091452-CBFA2173-317A-492E-B339-C6D2970F9189Q55019717-BA1AA421-A3A7-41A7-A685-D9BFF2B36E4AQ57023567-671152B9-C709-484C-A56B-FD965E29BB9EQ57641177-675EEC4A-2293-434A-9C6D-E22BC1E242F6Q85677146-A8DF5CB7-F275-4C6E-8723-B80877D68FD8Q86680169-4AEAAEF0-65FF-4B5B-BE59-712652BAB645Q86831841-3CE56E51-AAF6-4E4C-8E35-ECA20FBB1C01Q87502735-D63834C4-FC96-439B-890D-BE81169D3D21Q88010151-0ED14588-8702-4B1A-804C-B077BC11C403Q88100087-E6A1AB3C-EF77-454D-B1F1-1424AA8C74BAQ88361138-0D3B4CA4-CA7B-4ECC-A49E-C797D79E1A40Q89129177-9F07B2A5-DB03-4FCC-909D-13270E21BED8Q90104651-92FA7BF0-377A-42CF-AC1C-06D03B564D13Q90134361-D3E359A0-A0E2-4C64-856B-0391324F0F86Q90701129-EAC4D46A-7690-410C-9AE6-9D2B0678B083Q90905252-5D3CC739-CAF1-4FEC-ACE5-68BB78E5C33DQ91732776-26D8D100-C067-4499-ADC3-D416F7E6708EQ92686409-D3B55330-80B8-4D22-AE9B-B8104073DD8FQ92755448-E522DEFB-127C-4153-AF84-1DBC788020B6Q93098577-FDFC08D6-2B40-42B8-9BC5-108EBA1EAA35Q96023320-F0136919-A3DA-42D2-B24F-8804CD10BE33
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Lucien Marchand
@ast
Lucien Marchand
@en
Lucien Marchand
@es
Lucien Marchand
@nl
Lucien Marchand
@sl
type
label
Lucien Marchand
@ast
Lucien Marchand
@en
Lucien Marchand
@es
Lucien Marchand
@nl
Lucien Marchand
@sl
prefLabel
Lucien Marchand
@ast
Lucien Marchand
@en
Lucien Marchand
@es
Lucien Marchand
@nl
Lucien Marchand
@sl
P106
P1153
56406971700
P31
P496
0000-0001-9101-5002